Dialysate is the specially formulated fluid that flows on the opposite side of a semipermeable membrane from a patient’s blood during dialysis, drawing out waste products and excess electrolytes while supplying substances the body needs. It works through basic physical principles: dissolved particles move from where they are more concentrated to where they are less concentrated, and water follows osmotic gradients. The composition of dialysate is carefully engineered so that toxins like urea flow out of the blood, while beneficial substances like bicarbonate flow in. Getting that recipe right turns out to be far more nuanced than it sounds, and the choices clinicians make about dialysate composition have real consequences for heart rhythm, blood pressure, bone health, and survival.
How Dialysate Pulls Waste Out of Blood
The core mechanism is diffusion. During hemodialysis, blood flows through thousands of tiny hollow fibers inside a device called a dialyzer. Dialysate flows on the outside of those fibers. The fiber walls are porous enough to let small molecules pass through but too tight for blood cells and large proteins. Urea, creatinine, and other waste products are concentrated in the blood but absent or nearly absent from the fresh dialysate, so they naturally cross the membrane into the dialysate and get carried away.
The same principle works in reverse for substances the patient needs. Bicarbonate, for instance, is deliberately kept at a higher concentration in the dialysate than in the blood, so it diffuses into the blood and helps correct the acid buildup that failing kidneys can no longer handle. Dialysate is essentially a mirror image of healthy blood plasma, with the concentrations tweaked so that the right things move in the right direction.
Blood and dialysate almost always flow in opposite directions, a setup called countercurrent flow. This keeps a consistent concentration difference along the entire length of the dialyzer, which makes waste removal substantially more efficient. In one study comparing countercurrent to same-direction flow under otherwise similar conditions, urea clearance averaged about 24 ml/min with countercurrent flow versus roughly 18 ml/min with same-direction flow, and creatinine clearance showed a similar gap.1PubMed. Effect of the direction of dialysate flow on the efficiency of continuous arteriovenous haemodialysis That difference matters over a four-hour treatment session.
What Goes Into the Mix
Dialysate is produced by mixing purified water with two concentrated solutions, typically called an acid concentrate and a base concentrate, which are combined just before use. The final mixture contains sodium, potassium, calcium, magnesium, chloride, glucose, and a buffer (almost always bicarbonate today). The concentrations of these components are meant to approximate normal blood levels, but with deliberate offsets to drive the desired exchanges.2PubMed Central. Basics of base in hemodialysis solution: Dialysate buffer production, delivery and decontamination
You might assume these concentrations are precisely tailored for every patient based on rigorous evidence. In practice, dialysate composition is often chosen based on facility defaults or manufacturer specifications rather than individualized data. A review of the epidemiological evidence for dialysate bicarbonate, calcium, magnesium, and potassium found that concentrations are frequently selected “intuitively” and called for pragmatic clinical trials to fill the gaps.3PubMed Central. Dialysate Composition for Hemodialysis: Changes and Changing Risk The field knows these choices affect outcomes but still lacks definitive answers about the best targets for many of them.
Water Purity Is Non-Negotiable
Because a hemodialysis patient’s blood is separated from dialysate by only a thin membrane, the water used to make dialysate has to be far purer than drinking water. Over a single treatment session, a patient may be exposed to well over 100 liters of dialysate. Multiply that by three sessions a week, and the cumulative exposure to any contaminant becomes enormous. Municipal water contains trace amounts of chloramine, fluoride, aluminum, copper, and bacteria that are harmless to drink but dangerous when they can diffuse directly toward the bloodstream.
In the United States, the Association for the Advancement of Medical Instrumentation sets strict limits on specific contaminants in dialysis water, and some of those limits have been adopted into federal regulations. Despite this framework, contamination outbreaks have continued sporadically since the 1960s, causing at least 592 documented cases of illness and 16 deaths in the U.S.4PubMed Central. Hemodialysis and water quality Water treatment systems at dialysis facilities typically use a combination of carbon filtration, water softeners, and reverse osmosis to strip out chemical and microbial contaminants before the water ever reaches the dialysate mixing system.
Why Potassium Gets So Much Attention
Potassium is arguably the most nerve-racking electrolyte in dialysate prescribing. Patients with kidney failure tend to accumulate potassium between treatments because their kidneys can no longer excrete it efficiently. High potassium levels can trigger dangerous heart rhythms, so dialysate potassium is kept low enough to pull excess potassium out of the blood during treatment. But if the gradient between blood and dialysate potassium is too steep, the rapid shift can itself provoke arrhythmias. It is a balancing act with real stakes.
A large international study found that rapid electrolyte shifts during hemodialysis may contribute to arrhythmias and sudden death. That same study, however, found no meaningful clinical difference between dialysate potassium set at 2 versus 3 mEq/L, with adjusted hazard ratios near 1.0 for both mortality and arrhythmia.5PubMed Central. Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS) This suggests the choice between those two common concentrations may matter less than expected, though extremely low dialysate potassium (1 mEq/L or below) in a patient with already low blood potassium is a different story. A separate study in older adults starting hemodialysis examined whether the gradient between serum and dialysate potassium was independently associated with atrial fibrillation risk, and found no significant interaction between the two.6PubMed Central. Associations of Serum and Dialysate Potassium Concentrations With Incident Atrial Fibrillation in a Cohort Study of Older US Persons Initiating Hemodialysis for Kidney Failure The upshot is that both the blood level and the dialysate level matter, but they seem to act independently rather than multiplying each other’s risk.
Calcium and the Tug of War With Bones
Calcium in dialysate is another area where small changes have big consequences. The diffusion gradient between the ionized calcium in dialysate and in blood is the primary driver of how much calcium moves into or out of the patient during a session.7PubMed. The diffusion gradient between the ionized calcium concentration in the dialysate and in the blood is the main driving force of the net calcium mass balance during haemodialysis Set the dialysate calcium too high, and you load the patient with calcium that can deposit in blood vessels and soft tissue. Set it too low, and you pull calcium out of the blood, which may stimulate parathyroid hormone and worsen bone disease over time. Clinicians have to consider whether a patient is taking calcium-based phosphate binders, whether they are on vitamin D supplements, and what their parathyroid hormone levels look like before settling on a dialysate calcium concentration. There is no one-size-fits-all number.
Bicarbonate and the Acid-Base Tightrope
People with kidney failure develop a condition called metabolic acidosis because the kidneys can no longer excrete enough acid or regenerate enough bicarbonate. Dialysate supplies bicarbonate to correct this, and the dialysate bicarbonate concentration is one of the most commonly adjusted prescription variables. However, the evidence for choosing a specific target is surprisingly thin.
Both high and low serum bicarbonate levels have been linked to increased mortality in hemodialysis patients, but high levels often reflect poor nutrition and other health problems rather than being a cause of harm on their own. There has been concern about high-bicarbonate dialysate pushing patients into alkalosis (blood that is too alkaline) during treatment, but whether this truly causes harm remains unresolved.8PubMed Central. Bicarbonate Balance and Prescription in ESRD In practice, many facilities use a standard bicarbonate concentration and only adjust it for patients with persistently abnormal levels. The field recognizes that this is not ideal but lacks the clinical trial data to say exactly what the target should be.
Turning Down the Temperature
One variable you might not expect to find in a dialysate prescription is temperature. Standard dialysate is warmed to roughly body temperature, around 37°C. But during a typical session, the dialysis circuit can actually transfer heat into the patient, which causes blood vessels to dilate and blood pressure to drop. This phenomenon, called intradialytic hypotension, is one of the most common complications of hemodialysis and can cause dizziness, cramping, nausea, and in severe cases, damage to the heart and brain from repeated drops in blood flow.
Cooling the dialysate by even a degree or two helps counteract this. A Cochrane review found very low-quality but suggestive evidence that reducing dialysate temperature decreased episodes of intradialytic hypotension, though patients were more likely to feel uncomfortably cold.9Cochrane Database of Systematic Reviews. Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis A more refined approach involves isothermic dialysis, where the machine monitors the patient’s core temperature and adjusts dialysate temperature in real time to prevent any net heat gain. Research comparing these strategies found that active cooling slightly outperformed the isothermic approach at preventing the lowest blood pressure dips during sessions, possibly because cooling helps maintain the volume of blood circulating in the body.10PubMed Central. Control of core temperature and blood pressure stability during hemodialysis Temperature control is a simple, free intervention, which makes it appealing even if the evidence quality is still being built up.
How Peritoneal Dialysis Changes the Equation
Everything described so far applies mainly to hemodialysis, where blood runs through an external machine. Peritoneal dialysis uses a completely different setup. The patient’s own peritoneal membrane, the lining of the abdominal cavity, serves as the dialysis membrane. Dialysate is infused into the abdomen through a permanent catheter, dwells there for a set period while waste and fluid cross from the blood vessels in the peritoneum into the fluid, and then drains out.
Because peritoneal dialysis relies on osmosis to pull excess fluid out of the body, the dialysate needs an osmotic agent. Traditionally this is dextrose (glucose), and higher concentrations of dextrose pull more fluid. But long-term use of high-concentration dextrose can damage the peritoneal membrane and contribute to weight gain, high blood sugar, and elevated lipids. An alternative osmotic agent called icodextrin works differently. As an isosmotic solution, it generates fluid removal through a mechanism resembling colloid osmosis rather than the crystalline osmosis used by dextrose. It is absorbed more slowly from the peritoneal cavity, which means fluid removal lasts longer and the overall carbohydrate load is lower compared with medium- and high-concentration dextrose exchanges.11PubMed. Icodextrin: a review of its use in peritoneal dialysis Icodextrin is now commonly used for the long overnight dwell in automated peritoneal dialysis.
Prescribing peritoneal dialysis in children adds another layer of complexity. There is no single optimal prescription for all children, but the general principles call for scaling the fill volume to the child’s body surface area and adjusting dwell times individually, with special attention to phosphate removal and ultrafiltration capacity.12PubMed Central. Peritoneal dialysis prescription in children: bedside principles for optimal practice Even small details like the sodium concentration of the dialysate matter. A study in pediatric hemodialysis patients found that lowering dialysate sodium from 140 to 138 mEq/L improved pre-treatment blood pressure, reduced fluid gain between sessions, and was well tolerated.13PubMed. Effect of the decrease in dialysate sodium in pediatric patients on chronic hemodialysis
Dialysis Disequilibrium and Why Speed Matters
One risk specific to the speed of waste removal is a condition called dialysis disequilibrium syndrome. When hemodialysis pulls urea out of the blood rapidly, the urea concentration in the brain does not drop as fast because the blood-brain barrier slows the equilibration. This creates a temporary osmotic gradient that draws water into the brain, causing swelling. Symptoms range from headache and nausea to, in severe cases, seizures and loss of consciousness.14Dove Medical Press. Dialysis disequilibrium syndrome prevention and management The condition is most common in patients just starting dialysis whose urea levels are very high. Clinicians manage the risk by running the first few sessions at lower blood and dialysate flow rates, for shorter durations, so the drop in urea is more gradual.
Measuring Whether the Dialysate Did Its Job
The standard way to check whether a dialysis session removed enough waste is a metric called Kt/V, which essentially measures how thoroughly urea was cleared relative to the volume of water in the patient’s body. Traditionally this requires drawing blood samples before and after treatment, a process vulnerable to sampling errors. Newer technology can measure Kt/V in real time by shining ultraviolet light through the spent dialysate as it exits the machine. Waste products like urea absorb UV light at predictable wavelengths, so tracking that absorption gives a continuous readout of how much waste is being removed.
Validation studies have shown that UV-based Kt/V measurements are statistically indistinguishable from the traditional blood-based method, and the approach has the advantage of not requiring any needle sticks or blood draws during the session.15PubMed. Real-time Kt/V determination by ultraviolet absorbance in spent dialysate: technique validation A pilot study in patients with acute kidney injury also found a good correlation between UV-based and blood-based measurements, suggesting the technology could extend beyond routine chronic dialysis.16PubMed. Adequacy of hemodialysis in acute kidney injury: Real-time monitoring of dialysate ultraviolet absorbance vs. blood-based Kt/Vurea In practice, many modern dialysis machines now include optical sensors that passively monitor spent dialysate, giving clinicians feedback during the session rather than hours later.
Sorbent Technology and the Prospect of a Wearable Kidney
Standard hemodialysis uses a single pass of dialysate: once the fluid picks up waste, it is discarded. A typical session generates well over 100 liters of spent fluid. Sorbent-based systems take a radically different approach, recycling a small volume of dialysate by running it through a cartridge that strips out waste products and regenerates the fluid for reuse. The basic sorbent cartridge combines activated charcoal, urease (an enzyme that breaks down urea), a cation exchanger, and an anion exchanger.17PubMed. Sorbents in treatment of uremia: a short history and a great future
This approach dramatically reduces the volume of water needed, which is the key enabler for portable and potentially wearable dialysis devices. Current sorbent systems use a combination of urease, zirconium-based sorbents, and activated charcoal for regeneration. However, design challenges remain. The urease step generates ammonium and carbon dioxide as byproducts, and the sorbent releases sodium in exchange for the ammonium it absorbs. Managing those byproducts in a compact, patient-worn device has been a major engineering bottleneck, though short-term trials of wearable prototypes have been performed.18PubMed Central. The Revival of Sorbents in Chronic Dialysis Treatment If these problems are solved, a wearable artificial kidney could offer patients something close to continuous dialysis, more closely mimicking how real kidneys work around the clock rather than cramming all the waste removal into a few sessions per week.
The Environmental Footprint of Spent Dialysate
An underappreciated aspect of dialysis is what happens to all that fluid after it leaves the machine. Hundreds of liters per patient per week flow down the drain. Spent dialysate is characterized by high salinity and moderate levels of ammonia and phosphates, which in large quantities risk causing nutrient overloading in waterways. But the emerging contaminant picture is more complex than just salt and nutrients. Antibiotic-resistance genes and actual antibiotics (including beta-lactams, fluoroquinolones, and aminoglycosides) have been detected in dialysis sewage, raising concern about the spread of antimicrobial resistance in wastewater systems. Persistent chemicals like PFAS compounds have also been found. Even micro- and nanoplastics, likely shed from equipment wear during treatment, complicate the picture because they can act as carriers for resistant bacteria.19NefrologÃa (English Edition). Unlocking the circular economy potential of spent dialysate in hemodialysis
Ecotoxicological testing on small aquatic organisms suggests moderate ecological risk from undiluted spent dialysate, with chronic exposure being more concerning than acute. High nutrient concentrations could trigger eutrophication in receiving waters if the fluid reaches the environment without adequate treatment. These findings have prompted researchers to think about spent dialysate as a waste stream that deserves the kind of attention historically reserved for pharmaceutical manufacturing effluent, rather than just flushing it into the municipal sewer system and assuming the local treatment plant will handle everything.
Dialysate Prescriptions for Dogs
Hemodialysis is not exclusively a human treatment. Veterinary dialysis is available at specialty hospitals for dogs (and occasionally cats) with acute kidney injury or poisoning. The basic principles are the same, but the dialysate prescription requires species-specific adjustments. One area that has been studied is sodium management. A study of dogs receiving intermittent hemodialysis found that the dialysate sodium concentration correlated with the patient’s post-treatment plasma sodium, and that using the gradient between dialysate and patient sodium helped predict the final sodium level after treatment.20PubMed. Associations between dialysate sodium concentration and plasma sodium concentration of dogs receiving intermittent hemodialysis treatments Managing sodium carefully matters because overcorrecting a low sodium level too quickly can cause a dangerous neurological condition. The fact that the same dialysate-to-patient gradient concept works across species underscores how fundamental the physics of dialysis is: regardless of whose blood is on the other side of the membrane, the chemistry follows the same rules.